Table 2.
Main individual characteristics of the studies included.
| Authors | Year | Design | Country | Participants (N) | Age (Years) | Sex | Diagnosis method |
Serotype of dengue | Hospitalization (days) | Outcome | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 | Dengue | ||||||||||
| Braatz M et al. [23] | 2021 | Case series | Brazil | 1 | 16 | F | IgM, IgG, and PCR SARS-CoV-2 positive | PCR positive | NR | 21 | Discharged after 21 days of hospitalization |
| Reyes J et al. [24] | 2021 | Case report | Mexico | 1 | 42 | F | PCR SARS-CoV-2 positive | PCR positive | DENV- 1 | 18 | Discharged on day 24 after the onset of symptoms |
| Agudelo R et al. [25] | 2021 | Case report | Colombia | 2 | 24 | F | PCR SARS-CoV-2 positive | IgM and IgG positive | DENV- 1 | 6 | She was discharged after six days of hospitalization |
| 59 | M | PCR SARS-CoV-2 positive | IgM/IgG positive | NR | 63 | Died | |||||
| Bicudo N et al. [26] | 2020 | Case report | Brazil | 1 | 56 | F | PCR SARS-CoV-2 positive | IgM/IgG positive | DENV- 1 | 6 | Discharged after 6 days. |
| Lopes R [27]. | 2020 | Case report | Brazil | 1 | 39 | M | IgM, IgG and PCR SARS-CoV-2 positive | PCR positive | DENV- 1 | NR | Clinical improvement |
| Salvo C et al. [28] | 2020 | Case report | Argentina | 1 | 43 | M | PCR SARS-CoV-2 positive | IgM and NS1 positive. | NR | NR | Discharged. |
| Nakandakari et al. [29] | 2021 | Case report | Peru | 1 | 13 | F | IgM and IgG positive | NS1 positive. | NR | 5 | Discharged after five days |
| Rosso et al. [30] | 2021 | Cross-sectional | Colombia | 2 | NR | NR | PCR SARS-CoV-2 positive | PCR positive | DENV 1 - 4 | NR | NR |
| NR | NR | PCR SARS-CoV-2 positive | Seroconversion | NR | NR | NR | |||||
| Estofolete et al. [31] | 2020 | Case report | Brazil | 1 | 60 | F | PCR SARS-CoV-2 positive | NS1, IgM and IgG positive | NR | NR | Died after five days |
| Villamil-Gomez WE et al. [32] | 2021 | Case report | Colombia | 1 | 52 | M | PCR SARS-CoV-2 positive | IgG, IgM and PCR positive | DENV- 2 | 7 | Discharged, after 7 days |
| Radisic M et al. [33] | 2020 | Case report | Argentina | 1 | 25 | M | PCR SARS-CoV-2 positive | IgM and NS1 positive | NR | NR | He turned afebrile and was discharged one week after diagnosis. |
| Rosso M et al. [41] | 2021 | Case report | Argentina | 1 | 57 | F | PCR SARS-CoV-2 positive | PCR positive | NR | NR | Gradually improved over five days. |
| Quental K et al. [34] | 2021 | Case report | Brazil | 2 | 53 | F | PCR SARS-CoV-2 positive | NS1, IgG, IgM and PCR positive. | DENV- 1 | NR | NR |
| 57 | M | PCR SARS-CoV-2 positive | NS1, IgG, IgM and PCR positive. | DENV- 1 | NR | NR | |||||
| Schulte H et al. [35] | 2021 | Retrospective cohort | Brazil | 13 | NR | M | PCR SARS-CoV-2 positive | NS1 positive | NR | NR | NR |
| NR | F | PCR SARS-CoV-2 positive | NS1 positive | NR | NR | Discharged after seven days. | |||||
| NR | F | PCR SARS-CoV-2 positive | IgM positive | NR | NR | Discharged after four days. | |||||
| NR | M | PCR SARS-CoV-2 positive | NS1 positive | NR | NR | NR | |||||
| NR | F | PCR SARS-CoV-2 positive | IgM positive | NR | NR | NR | |||||
| NR | M | PCR SARS-CoV-2 positive | NS1 positive | NR | NR | NR | |||||
| NR | M | PCR SARS-CoV-2 positive | IgM positive | NR | NR | NR | |||||
| NR | F | PCR SARS-CoV-2 positive | IgM positive | NR | NR | NR | |||||
| NR | M | PCR SARS-CoV-2 positive | IgM positive | NR | NR | NR | |||||
| NR | F | PCR SARS-CoV-2 positive | IgM positive | NR | NR | NR | |||||
| NR | F | PCR SARS-CoV-2 positive | NS1 positive | NR | NR | NR | |||||
| NR | M | PCR SARS-CoV-2 positive | IgM positive | NR | NR | NR | |||||
| NR | F | PCR SARS-CoV-2 positive | NS1 positive | NR | NR | Discharged after five days. | |||||
| Valdés J et al. [36] | 2020 | Case report | Ecuador | 1 | 50 | M | IgG, IgM and PCR SARS-CoV-2 positive. | IgM positive | NR | NR | Discharged for 26 days |
PCR: Polymerase Chain Reaction.
NR: No report.
M/F: Male/Female.
DENV 1-4: dengue virus serotype 1 and 4.
NS1: nonstructural protein 1.